Navigation Links
Observant LLC Expands Senior Management Team

Strategic market research partner to the pharmaceutical and biotechnology

industries strengthens specialist expertise

BOSTON, Jan. 3 /PRNewswire/ -- Observant LLC has announced the appointment of two senior executives with a passion for research excellence and a commitment to client service. John Hartman, Ph.D., a social scientist and statistician, has joined the firm as Vice President. Dr. Hartman's research has focused on the mathematical analysis of cross-national healthcare data; and his programming work has emphasized how best to present the complex relationships he uncovers to his clients in intuitive visual forms that are business actionable. Advances in computational power and statistical methodology have dramatically changed the ways in which data are analyzed and displayed, but such methods cannot be applied in a rote, unthinking manner. As Dr Hartman notes, "Real gains can be made in the way we display the results of our quantitative analyses. Many of the current visual displays fail to show variations in the precision of our estimates or how a subset of respondents may possess very different attitudes from the larger sample." Dr. Hartman believes that it is important to bear in mind that it's the creative mixture of therapeutic category expertise and rigorous data analysis that yields business critical insights.

(Photo: )

(Photo: )

The company is also pleased to announce that Jennifer Potter, Ph.D., M.P.H., has joined the firm as a Director. A clinical psychologist, Dr. Potter joins the firm from Harvard Medical School where her clinical research specialties included pain, substance use disorders, and the design and conduct of clinical trials. She has been a market research consultant for several years, managing studies across a range of therapeutic categories. Dr. Potter strengthens the company's scientific expertise in understanding the business implications of clinical trial design choices. As clinical trial designs become increasingly complex, how these impact physician prescribing behaviors becomes even more critical. Dr. Potter also believes strongly that knowledge of health behavior and clinical behavior should be applied to market research. According to Dr. Potter, "While gauging a doctor's or patient's enthusiasm for a product is a good first step, applying psychological principles of behavior change to market research enhances our clients' ability to influence product uptake."

Observant LLC is a strategic market research partner to the pharmaceutical and biotechnology industries worldwide. The firm offers a full spectrum of research and consulting services including analytically sophisticated quantitative studies and best-in-class qualitative research studies. Observant LLC supports its clients by conducting research in North America, Europe, Asia, South America, and Australia. Observant LLC principals and personnel have cross-industry backgrounds in consulting and public health and have published extensively on research methods and health science. For more information about the company, or to contact Dr. Hartman or Dr. Potter, please visit:

SOURCE Observant LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
2. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
3. CSL Behring Expands Into Middle East Market with Haemate(R) P
4. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
5. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
6. Siemens Expands the SOMATOM Definition(TM) Line With Worlds First Adaptive CT Scanner
7. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
8. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
9. Imaging Diagnostic Systems Expands Key Patent Coverage
10. EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD
11. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, a ... Emily Leproust, Ph.D., Twist Bioscience chief executive officer, ... Conference on December 1, 2015 at 3:10 p.m. ... York City. --> ... . Twist Bioscience is on Twitter. Sign up ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 list ... facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up ...
(Date:11/24/2015)... CHARLOTTESVILLE, Va. , Nov. 24, 2015 /PRNewswire/ ... company focused on discovering drugs for metabolic disorders, ... Watkins to its Board of Directors (BOD). ... executive officer of Human Genome Sciences (HGS), and ... Industry Organization. Jim Powers , Chairman ...
(Date:11/24/2015)... ... November 24, 2015 , ... Whitehouse Laboratories is pleased ... The new stand-alone facility will be strictly dedicated to basic USP 61, USP 62 ... clients the chance to have complete chemistry and micro testing performed by one supplier. ...
Breaking Biology Technology:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):